$2.37 -0.06 (-2.47%)
12/3/2009 4:00 PM

Clarient, Inc. (CLRT)

CAPS Rating: 3 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Current Price $2.37 Mkt Cap $185.87M
Open $0.00 P/E Ratio 0.00
Prev. Close $2.43 Div. (Yield) N/A (N/A)
Daily Range $2.36 - $2.47 Volume 536,268
52-Wk Range $1.00 - $4.43 Avg. Daily Vol. 993,000

CLRT News and Commentary

Caps

How do you think CLRT will perform vs the S&P 500?

Add Stock to Watchlist

All Members

109 Outperform
14 Underperform
 

All-Star Members

39 Outperform
7 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top CLRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

pathompson1 (50.78)
Submitted June 28, 2008

With a proprietary diagnostic system that detects the most accurate results in the industry, this company is taking market share quickly and with a small sales force at that!. Clarient is a relatively small start up company in the diagnostic arena… More

0 Comments | Reply | Report this Post

drnerdo2k2 (30.82)
Submitted January 22, 2007

Turned up on a screen for companies with hideous balance sheets. Current ratio has been dwindling and recently slipped to 0.74. Cash flow and earnings negative for a decade+, only question is if they'll be able to keep finding financing. Total… More

3 Comments | Reply | Report this Post
CLRT VS S&P 500 (SPY)

Fools bullish on CLRT are also bullish on:

Fools bearish on CLRT are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about CLRT.

Recs

0
Member Avatar spundun (87.06) Submitted: 10/9/2009 4:04:14 PM : Outperform Start Price: $3.84 CLRT Score: -40.71

HT porte..

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Fineearth (< 20) Submitted: 3/21/2009 1:08:14 PM : Outperform Start Price: $1.73 CLRT Score: -4.65

Trending in the right direction - given the investment climate they are managing cash well and able to maintain funding.

Report this Post 0 Comments | Reply | Permalink

Recs

1
Member Avatar pathompson1 (50.78) Submitted: 6/28/2008 12:50:00 AM : Outperform Start Price: $2.05 CLRT Score: +26.58

With a proprietary diagnostic system that detects the most accurate results in the industry, this company is taking market share quickly and with a small sales force at that!. Clarient is a relatively small start up company in the diagnostic arena that is starting to see the return on its investments. With a few quarters showing positive figures on its balance sheet, these guys are going to boooom!!! Clarient was established by a team of industry guru's from Roche, Safeguard Scientifics, Immucor and AmeriPath alike.

Report this Post 0 Comments | Reply | Permalink
View All 12 Pitches »

Leaderboard

Find the members with the highest scoring picks in CLRT.

Score Leader

skerzz

skerzz (39.08) Score: +75.81

The Score Leader is the member with the highest score across all their picks in CLRT.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
skerzz 39.08 12/18/2006 Outperform 3W $1.50 +58.00% -17.81% +75.81
x3abodx 67.76 1/5/2007 Outperform 5Y $1.50 +58.00% -17.10% +75.10
jonclaude1 92.86 1/22/2007 Outperform 3M $1.52 +55.92% -18.11% +74.03
meyhoedhome < 20 1/8/2007 Outperform 3M $1.64 +44.51% -16.79% +61.30
Bullerina < 20 1/12/2007 Outperform 3W $1.65 +43.64% -17.56% +61.20 1 Comment
radsMD 25.35 1/16/2007 Outperform 5Y $1.68 +41.07% -18.11% +59.18 1 Comment
todanc < 20 1/9/2007 Outperform 3M $1.69 +40.32% -16.95% +57.27
DGood2 63.78 12/28/2006 Outperform 3M $1.70 +39.41% -17.73% +57.14
dsmeathers 59.21 12/28/2006 Outperform 3W $1.70 +39.41% -17.73% +57.14
esebeus 53.80 12/29/2006 Outperform 3Y $1.73 +36.99% -17.52% +54.51 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRWBaird 79.67 6/11/2009 Outperform NS $3.55 -33.24% +17.92% -51.16
TrackRothCapital 76.40 4/16/2009 Outperform NS $2.51 -5.58% +29.79% -35.37
TrackPacificGrow 83.75 3/30/2007 Outperform NS $2.05 +15.61% -17.68% +33.29
TrackMDB < 20 3/21/2007 Outperform NS $1.96 +20.92% -17.25% +38.17

Featured Broker Partners